Magazine

Issue 1-2015

Download Issue 1-2015 (pdf)

Letter from the Editor
Magnus Gisslén

CROI 2015
Per Lundblad

Hepatitis C Price war begins
Graeme Moyle

In search for better nucleos(t)ides. Is TAF the answer?
Jose Arribas

Smoking shortens life more than HIV, Hepatitis C. Varenecline may help stop
Graeme Moyle

What´s new in prevention?
Christine Katlama

Partnering for cure meeting in Stockholm
Per Lundblad

Seven novel HCV DAAs approved - confused by too many options?
Heiner Wedemeyer

Notes 2015
Leo Flamholc

Topical Conferences

Issue 4-2014

Download Issue 4-2014 (pdf)

Letter from the Editor
Magnus Gisslén

HIV Drug Therapy Congress Glasgow 2014
Per Lundblad

Where now for Protease inhibitors?
Graeme Moyle

PROTEA: the end of the road of protease inhibitor monotherapy?
José R Arribas

HIV News from Glasgow 2014
Christine Katlama

HIV Nordic Conference Stockholm 2014
Per Lundblad

Satellite Symposiums at the HIV Nordic Conference
Per Lundblad

AASLD 2014: the era of IFN-free hepatitis C treatment is entering clinical practice!
Heiner Wedemeyer

Issue 3-2014

Download Issue 3-2014 (pdf)

Letter from the Editor
Magnus Gisslén

6th Gilead Nordic Summer HIV Meeting
Per Lundblad

Nucleoside Free Zones
Graeme Moyle

SALT & OLE: ”If you can beat them, join them” (but just one of them)
José R Arribas

The 4th European Workshop on HIV Infection in the CNS (HANSA)
Aylin Yilmaz

The HCV drug-rally is ongoing: Simeprevir and Daclatasvir approved by EMA!
Heiner Wedemeyer

News from the Summer/Winter World AIDS Conference, Melbourne
Christine Katlama

Issue 2-2014

Download Issue 2-2014 (pdf)

Letter from the Editor
Magnus Gisslén

Hepatitis treatment at the ILC in London
Per Lundblad

HHS Guidelines Update: What you shouldn´t miss
José R. Arribas

Tubular alarm bells
Graeme Moyle

News from CROI & EASL on Treatment of Hepatitis C in patients with HIV
Jürgen Kurt Rockstroh

EASL 2014: The ”100 %” Melting!
The NEJM: The Hepatitis C Journal!
Heiner Wedemeyer

Integrase Inhibitors in Clinical Practice: Today and Tomorrow
Christine Katlama

Issue 1-2014

Download Issue 1-2014 (pdf)

Letter from the Editor
Magnus Gisslén
CROI 2014
Per Lundblad
NEAT 991 and ACTG 5257: sparing NUCS or NON-NUCS
José R. Arribas
Dr Graeme Moyle in UK
Per Lundblad
Drug Interactions with Intergrase Inhibitors
Graeme Moyle
The European Sofosbuvir Label: From Evidence-based to EMA-based Medicine
Heiner Wedemeyer
A Melting Pot from CROI 2014
Christine Katlama

Issue 4-2013

Download Issue 4-2013 (pdf)

HIV treatment guidelines
Magnus Gisslén

14th EACS Conference in Brussels
Per Lundblad

14th European AIDS Conference: Update on ART
José Arribas

HIV-associated lymphoma: Treatment update
Hans Hagberg

AIDS Vaccine Congress in Barcelona
Per Lundblad

The price of antiretroviral therapy
Graeme J. Moyle

HIV & Hepatitis News
Leo Flamholc

New ARV drugs: What’s in the pipeline?
Christine Katlama

The path towards IFN-free therapy of hepatitis C
Part 4: We made it! IFN-free therapy is reality!
Heiner Wedemeyer

Topical Conferences in 2014

Issue 3-2013

Download Issue 3-2013 (pdf)

Cure for hepatitis C achieved, but what about HIV?
Magnus Gisslén

The 5th Nordic Summer HIV Meeting
Per Lundblad

Women and Children last. Is drug development leaving the most in need behind?
Graeme J. Moyle

HIV & Hepatitis News
Leo Flamholc

ART and Cure – The post treatment controllers
Christine Katlama

The path towards IFN-free therapy of hepatitis C
Part 3: We need to be prepared
How to ensure access to novel antiviral therapies against hepatitis C?
Heiner Wedemeyer

SECOND-LINE & EARNEST
Nucleosides strike back
José Arribas

Issue 2 - 2013

Download Issue 2 - 2013 (pdf)

CD4 Decline in HIV-infected Patients During Treatment
Magnus Gisslén

HANSA 2013 in Berlin
Aylin Yilmaz

Dolutegravir for Salvage Therapy
José Arribas

The Path Towards IFN-free Therapy of Hepatitis C Part 2: We are getting closer
Heiner Wedemeyer

Topical Conferences in 2013

Professor Manuel Battegay - New President of EACS
Per Lundblad

Antiretroviral Therapy: Imagine the Future
Christine Katlama

HIV & Hepatitis News
Leo Flamholc

Does One Size Fit All?
Graeme J. Moyle

Issue 1 - 2013

Download Issue 1-2013 (pdf)

Letter from the Editor
Magnus Gisslén

CROI 2013 in Atlanta
Per Lundblad

Declining HIV Drug Resistance in Europe
Graeme J. Moyle

HIV Cure: Breaking News
Christine Katlama

Antiretrovirals: New and Old
José Arribas

Topical Conferences in 2013

HIV & Hepatitis News
Leo Flamholc

The (longer than expected?) Path Towards IFN-free Therapy of Hepatitis C
Heiner Wedemeyer

Issue 4 2012

Download Issue 4 - 2012 (pdf)

In this issue:
Letter from the Editor
Magnus Gisslén
Eleventh International Congress on Drug Therapy in HIV Infection
Per Lundblad
HIV11: More on viral escape in cerebrospinal fluid, CPE score, boosted protease inhibitor monotherapy and neurocognitive impairment
José Arribas
New Treatments for HCV. Report from the AASLD Meeting in Boston November 2012
Ola Weiland
Towards an HIV Cure: The Scientific Strategy is Launched
Alain Lafeuillade
Time for Universal Testing
Graeme J. Moyle
HIV & Cancer: A Dangerous Gang
Christine Katlama
Interview with Christine Katlama
Per Lundblad
Topical Conferences in 2013

 

Pages